DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Weber JS, D'Angelo SP, Minor D. et al.
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): A Randomised, controlled, open-label, phase 3 trial.
Lancet Oncol 2015;
16: 375-384
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.